1. Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy. (27th December 2018) Authors: Luen, S J; Salgado, R; Dieci, M V; Vingiani, A; Curigliano, G; Gould, R E; Castaneda, C; D'Alfonso, T; Sanchez, J; Cheng, E; Andreopoulou, E; Castillo, M; Adams, S; Demaria, S; Symmans, W F; Michiels, S; Loi, S Journal: Annals of oncology Issue: Volume 30:Number 2(2019) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗